FDA Submits Information Collection for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, to establish additional criteria and procedures for classifying over-the-counter drugs as Generally Recognized as Safe and Effective and Not Misbranded.